Total: 1 |
|
PMID (PMCID) | ||
---|---|---|
30531139 |
MALE | Middle Aged |
[Thrombotic microangiopathy developing subsequent to tocilizumab therapy in a patient with TAFRO syndrome]. | ||
Ito S, Tsutsumi Y, Kikuchi R, Matsuoka S, Shimoyama N. Rinsho Ketsueki. 2018;59(11):2432-2437. |
||
The pathological diagnosis from lymph node biopsy suggested multicentric Castleman's disease of the plasma cell type; however, the presence of high IL-6 levels, myelofibrosis, thrombocytopenia, anasarca, renal dysfunction, and hepatosplenomegaly led to a definitive diagnosis of TAFRO syndrome. |